Vident Investment Advisory’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,488
Closed -$1.19M 1336
2021
Q4
$1.19M Buy
4,488
+585
+15% +$158K 0.03% 645
2021
Q3
$1.13M Buy
+3,903
New +$1M 0.03% 627

Other funds holding RGEN

Vident Investment Advisory's RGEN Position: Q1 2022 in Review

Vident Investment Advisory sold out of Repligen (RGEN) in Q1 2022, closing a stake of 4,488 shares — an estimated $1.19M sold.

Vident Investment Advisory first reported a position in RGEN in Q3 2021 and held it in 2 quarters. The position peaked at $1.19M in Q4 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • Vident Investment Advisory reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 4,488 Repligen shares in Q1 2022, an estimated $1.19M.
  • Vident Investment Advisory first reported a position in Repligen in Q3 2021 and held it in 2 quarters.
  • Vident Investment Advisory's Repligen position peaked at $1.19M in Q4 2021.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Vident Investment Advisory's 13F filing for Q1 2022, filed 16 May 2022.